Meet Replior at SCOPE Europe 2026

De-risk the trial. Protect the signal.

Clinical trials lose signal in more ways than one. Participants disengage. Subjective endpoints drift. Protocol complexity creates friction. Important real-world variables go unmeasured.

Replior brings EDC, behavioural-science eCOA and clinical-grade sensors together to address these risks across the trial — from study design and participant engagement to objective measurement.

About the SCOPE Summit Europe

SCOPE Summit Europe brings together clinical research leaders from pharma, biotech, CROs, sites and technology providers to explore the latest developments in clinical trial planning and operations.

The conference covers key areas including trial design and protocol development, patient engagement, clinical data strategy and AI, risk-based quality management, and site operations, with a focus on improving how clinical trials are designed and delivered.

Discover what we’re bringing to the event

Replior EDC

Model the study, not the forms.

Most EDCs start with the CRF and layer study logic on top. Replior starts with the protocol.

Visit schedules, event branches and conditional pathways are part of the underlying study model, allowing data collection to follow the study rather than forcing the study into a form-first architecture.

Designed with senior data-management expertise, the platform gives sites, data managers, monitors, sponsors and biostatisticians workflows built around how they actually work. Its modern microservices, APIs and real-time data pipeline also provide the architecture for future governed AI services.

Fit the system to the study. Not the study to the system.

Replior eCOA/ePRO

Change behaviour, don’t just collect data.

Digitising a paper diary solved data capture. It did not solve motivation.

Replior’s eCOA is built around behavioural-science principles designed to sustain participation through the difficult parts of a trial. Meaningful contribution, visible progress, study-specific messaging and adaptive content reinforce why participation matters — rather than relying on reminders alone.

The results can be substantial: 99% retention at Week 28 in a long-duration dermatology study, compared with ~80% across two comparable prior studies from the same sponsor and indication, and 97% daily diary completion in a 52-week Phase III study.

Better engagement protects better data.

Wearable Sensors

Measure what patients can’t report.

Some signals are difficult to remember. Others are impossible to see.

Replior’s in-house sensors add continuous, objective measurement to the participant-reported picture.

ScratchSense captures scratching and sleep, providing objective measurement between visits where retrospective itch reporting can introduce recall bias.

RaySense measures real-world UV, visible and infrared exposure — making an environmental variable measurable rather than leaving it as uncontrolled noise.

Objective measurement. In the real world. Between visits.

JOIN OUR SESSION

Trial De-Risking: Three Sources of Noise That Quietly Sink Clinical Trials

Every day of Phase III delay costs ~$56,000, yet sponsors still lose signal to three controllable sources of noise: patient attrition, subjective endpoint variance, and unmeasured environmental exposure.

This session presents a practical framework combining behavioural-science eCOA with sensor-based digital endpoints—ScratchSense for continuous itch/sleep quantification and RaySense for UV, visible, and IR exposure. Attendees will explore real-world retention outcomes, sample-size reduction strategies, and a live ScratchSense demo comparing recall-based vs. continuous itch measurement.

See our complete platform at SCOPE

EDC

Measure what
patients can't report

New-generation EDC designed by data managers, with protocol-first study configuration and an AI-ready architecture.

eCOA/ePRO

Behavioural
science–driven.

Designed around participant motivation, with visible progress, tailored messaging and adaptive content.

Sensors

Objective,
clinical-grade.

ScratchSense for continuous scratch and sleep measurement. RaySense for UV, visible and IR exposure.

Meet Replior in Barcelona

Tell us where you see the risk: participant retention, protocol complexity, endpoint variability, environmental exposure — or somewhere else entirely.

We’ll show you how we would approach it across EDC, eCOA and objective digital measurement.

Visit us at Booth 25

SCOPE Summit Europe · InterContinental Barcelona (Fira Center)